Dr. Santosh Chokhani has over thirty years of experience in Information Technology, including fifteen years of experience in Information Security. Dr. Chokhani is a world-renowned expert in PKI and in third party product and system evaluations. Having made numerous contributions to the ISO, Internet, and FIPS standards in the area of PKI and information security, some of the PKI standards contributions include development of the certification path processing rules for X.509, discovery of policy mapping flaw and correction, development of CRL processing rules, discovery of security flaw with CRL processing and solutions to the flaw, discovery of security flaw in cryptographic parameters processing and solution to the flaw, development of Internet RFC (2527 and 3647) for CP/CPS.
Dr. Chokhani has made numerous technical contributions to the PKI for Johnson & Johnson; SAFE (Bio Pharma Bridge PKI), CertiPath (Aerospace Bridge PKI), and Department of Defense. He has made several contributions in the area of security and interoperability among the various Government and industry PKI. Dr. Chokhani has also advised Department of Justice, Department of State, Drug Enforcement Administration, National Institutes of Standards and Technology, and United States Postal Service in the areas of PKI and PK enabled applications.
Dr. Chokhani is founder of two high-end information security consulting companies: CygnaCom Solutions and Orion Security Solutions and he also founded and operated Common Criteria testing and FIPS 140-2 testing laboratories at CygnaCom.
Dr. Chokhani was a member of the Secretary of Commerce Industry Advisory Panel on Key Management Infrastructure. He was also a member of the Common Criteria Crypto Working Group and is a past member of the National Security Agency’s Technical Review Board (TRB) and NSA Senior Validator for Common Criteria.
Dr. Chokhani holds BS in Electrical Engineering from the University of Bombay and MS and Ph. D. in Electrical Engineering from Rutgers University. Dr. Chokhani’s Ph. D. thesis was in the area of application of Artificial Intelligence to Biomedicine. |